Evotec
Edit

Evotec

http://www.evotec.com/
Last activity: 29.02.2024
Categories: ITInvestmentFinTechExchangeDrugDevelopmentBioTechMedtechProductScience
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 4,000 highly qualified people. The Company’s 14 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
Followers
3.66K
Followers
42.1K
Website visits
52.7K /mo.
Mentions
123
Location: Germany, Hamburg
Employees: 1001-5000
Total raised: $513.08M
Founded date: 1993

Investors 4

Funding Rounds 4

DateSeriesAmountInvestors
10.02.2023-$160.48M-
16.12.2021Grant$18M-
12.10.2020-$294.98M-
01.09.2013-$39.63M-

Mentions in press and media 123

DateTitleDescriptionSource
23.01.2024Ahead of Medicare drug price reform, pharma’s drug pricing h...Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne...statnews.c...
14.11.2023Autobahn Labs Announces Key Licensing Milestones in Alliance...I’m thrilled to see our early partnerships bearing fruit. The two startups, in which we have already...einpresswi...
08.08.2023Autobahn Labs Appoints Chief Executive OfficerBrendan O'Leary - CEO, Autobahn Labs Experienced Life Sciences Executive and Venture Capitalist Dr. ...einpresswi...
09.05.2023Autobahn Labs Announces Strategic Collaboration with the Sal...New Collaboration Adds to Autobahn Labs’ Transformative Biotech Incubator Model in California and th...einpresswi...
07.04.2023Cyber Attack on EvotecHAMBURG, GERMANY / ACCESSWIRE / April 7, 2023 / Evotec SE ((Frankfurt Stock Exchange: EVT, MDAX/TecD...einpresswi...
13.02.2023Hamburg-based Evotec bags €150M loan from EIB to accelerate ...Hamburg-based Evotec, a life sciences company, announced on Friday, February 10, that it has raised ...siliconcan...
10.02.2023Evotec Receives € 150 m Loan from European Investment BankFINANCING FOR 3 CORE PILLARS: R&D ACTIVITIES, EQUITY INVESTMENTS AND CONSTRUCTION OF MANUFACTURI...accesswire...
10.02.2023Evotec Receives € 150 m Loan from European Investment BankFINANCING FOR 3 CORE PILLARS: R&D ACTIVITIES, EQUITY INVESTMENTS AND CONSTRUCTION OF MANUFACTURI...einpresswi...
26.01.2023Evotec Announces Agreement with Janssen to Develop Immune-Ba...STRATEGIC PARTNERSHIP LEVERAGES EVOTEC'S EXPERTISE & INTEGRATED PLATFORM FOR DISCOVERY AND DEVEL...einpresswi...
03.11.2022Evotec Completes Acquisition of Central Glass GermanyAS EVOTEC DRUG SUBSTANCE (GERMANY) GMBH, THE ACQUISITION STRENGTHENS EVOTEC'S CLINICAL AND COMMERCIA...accesswire...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In